Skip to main content
. Author manuscript; available in PMC: 2009 Oct 19.
Published in final edited form as: Am J Trop Med Hyg. 2009 Apr;80(4):528–535.

FIGURE 4.

FIGURE 4

Plasma concentration-time profiles of pafuramidine (A) and its active metabolite DB75 (B). For each panel, curves on the left represent the day −8 treatment arm and those on the right represent the day −1 treatment arm. Samples with plasma levels < 0.25 ng/mL are not plotted. Open symbols = subject in day −8 treatment group in whom malaria did not develop.